Related references
Note: Only part of the references are listed.Macrophage LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1) Is Required for the Effect of CD47 Blockade on Efferocytosis and Atherogenesis-Brief Report
Paul A. Mueller et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2022)
Loss of myeloid cell-specific SIRPα, but not CD47, attenuates inflammation and suppresses atherosclerosis
Bhupesh Singla et al.
CARDIOVASCULAR RESEARCH (2022)
Inflammation and cardiovascular diseases: lessons from seminal clinical trials
Luca Liberale et al.
CARDIOVASCULAR RESEARCH (2021)
ODC (Ornithine Decarboxylase)-Dependent Putrescine Synthesis Maintains MerTK (MER Tyrosine-Protein Kinase) Expression to Drive Resolution
Arif Yurdagul et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)
Heart Disease and Stroke Statistics-2021 Update A Report From the American Heart Association
Salim S. Virani et al.
CIRCULATION (2021)
Effect of CD47 Blockade on Vascular Inflammation
Kai-Uwe Jarr et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Deficiency of macrophage PHACTR1 impairs efferocytosis and promotes atherosclerotic plaque necrosis
Canan Kasikara et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Protective Functions of Liver X Receptor α in Established Vulnerable Plaques: Involvement of Regulating Endoplasmic Reticulum-Mediated Macrophage Apoptosis and Efferocytosis
Xinyu Che et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
Deficiency of histone lysine methyltransferase SETDB2 in hematopoietic cells promotes vascular inflammation and accelerates atherosclerosis
Xinbo Zhang et al.
JCI INSIGHT (2021)
Bench-to-Bedside in Vascular Medicine Optimizing the Translational Pipeline for Patients With Peripheral Artery Disease
Tom Alsaigh et al.
CIRCULATION RESEARCH (2021)
Association of Statin Treatment With Progression of Coronary Atherosclerotic Plaque Composition
Alexander R. van Rosendael et al.
JAMA CARDIOLOGY (2021)
Resolvin D1 promotes the targeting and clearance of necroptotic cells
Brennan D. Gerlach et al.
CELL DEATH AND DIFFERENTIATION (2020)
Macrophage Metabolism of Apoptotic Cell-Derived Arginine Promotes Continual Efferocytosis and Resolution of Injury
Arif Yurdagul et al.
CELL METABOLISM (2020)
Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis
Alyssa M. Flores et al.
NATURE NANOTECHNOLOGY (2020)
Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies
Mark P. Chao et al.
FRONTIERS IN ONCOLOGY (2020)
Initial Invasive or Conservative Strategy for Stable Coronary Disease
David J. Maron et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Targeting macrophage checkpoint inhibitor SIRPα for anticancer therapy
Jie Liu et al.
JCI INSIGHT (2020)
18F-Fluorodeoxyglucose-Positron Emission Tomography Imaging Detects Response to Therapeutic Intervention and Plaque Vulnerability in a Murine Model of Advanced Atherosclerotic Disease-Brief Report
Kai-Uwe Jarr et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Clonally expanding smooth muscle cells promote atherosclerosis by escaping efferocytosis and activating the complement cascade
Ying Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
siRNA nanoparticles targeting CaMKIIγ in lesional macrophages improve atherosclerotic plaque stability in mice
Wei Tao et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
SIRPα on Mouse B1 Cells Restricts Lymphoid Tissue Migration and Natural Antibody Production
Katka Franke et al.
FRONTIERS IN IMMUNOLOGY (2020)
CD47 prevents the elimination of diseased fibroblasts in scleroderma
Tristan Lerbs et al.
JCI INSIGHT (2020)
Efferocytosis in health and disease
Amanda C. Doran et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Smooth Muscle Cells Contribute the Majority of Foam Cells in ApoE (Apolipoprotein E)-Deficient Mouse Atherosclerosis
Ying Wang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Nanoparticle Therapy for Vascular Diseases
Alyssa M. Flores et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Living on the Edge: Efferocytosis at the Interface of Homeostasis and Pathology
Sho Morioka et al.
IMMUNITY (2019)
Biological profile of monocyte-derived macrophages in coronary heart disease patients: implications for plaque morphology
Sonia Eligini et al.
SCIENTIFIC REPORTS (2019)
From Detecting the Vulnerable Plaque to Managing the Vulnerable Patient JACC State-of-the-Art Review
Armin Arbab-Zadeh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean-Claude Tardif et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Myeloid Slc2a1-Deficient Murine Model Revealed Macrophage Activation and Metabolic Phenotype Are Fueled by GLUT1
Alex J. Freemerman et al.
JOURNAL OF IMMUNOLOGY (2019)
Phagocytosis checkpoints as new targets for cancer immunotherapy
Mingye Feng et al.
NATURE REVIEWS CANCER (2019)
Proefferocytic Therapy Promotes Transforming Growth Factor-β Signaling and Prevents Aneurysm Formation
Yoko Kojima et al.
CIRCULATION (2018)
Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial
Rasha Al-Lamee et al.
LANCET (2018)
Efferocytosis induces a novel SLC program to promote glucose uptake and lactate release
Sho Morioka et al.
NATURE (2018)
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma
Ranjana Advani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis
Bishuang Cai et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms
Joanna M. M. Howson et al.
NATURE GENETICS (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer
Paola A. Betancur et al.
NATURE COMMUNICATIONS (2017)
Coronary Atherosclerotic Vulnerable Plaque: Current Perspectives
Christodoulos Stefanadis et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Mitochondrial Fission Promotes the Continued Clearance of Apoptotic Cells by Macrophages
Ying Wang et al.
CELL (2017)
CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis
Yoko Kojima et al.
NATURE (2016)
Activation of the pluripotency factor OCT4 in smooth muscle cells is atheroprotective
Olga A. Cherepanova et al.
NATURE MEDICINE (2016)
Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis
Denuja Karunakaran et al.
SCIENCE ADVANCES (2016)
Role of milk fat globule-epidermal growth factor 8 in colonic inflammation and carcinogenesis
Ryusaku Kusunoki et al.
JOURNAL OF GASTROENTEROLOGY (2015)
Macrophage SR-BI mediates efferocytosis via Src/PI3K/Rac1 signaling and reduces atherosclerotic lesion necrosis
Huan Tao et al.
JOURNAL OF LIPID RESEARCH (2015)
KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis
Laura S. Shankman et al.
NATURE MEDICINE (2015)
Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice
Gabrielle Fredman et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential
Jie Liu et al.
PLOS ONE (2015)
Anti-inflammatory therapies for cardiovascular disease
Paul M. Ridker et al.
EUROPEAN HEART JOURNAL (2014)
Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis
Yoko Kojima et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Engineered SIRPα Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies
Kipp Weiskopf et al.
SCIENCE (2013)
Genetic Dissection of TAM Receptor-Ligand Interaction in Retinal Pigment Epithelial Cell Phagocytosis
Tal Burstyn-Cohen et al.
NEURON (2012)
A Tale of Coronary Artery Disease and Myocardial Infarction
Elizabeth G. Nabel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Necrotic cell death in atherosclerosis
Wim Martinet et al.
BASIC RESEARCH IN CARDIOLOGY (2011)
Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy
Mark P. Chao et al.
BLOOD (2011)
Macrophages in the Pathogenesis of Atherosclerosis
Kathryn J. Moore et al.
CELL (2011)
Intraplaque haemorrhages as the trigger of plaque vulnerability
Jean-Baptiste Michel et al.
EUROPEAN HEART JOURNAL (2011)
Shedding of the Mer Tyrosine Kinase Receptor Is Mediated by ADAM17 Protein through a Pathway Involving Reactive Oxygen Species, Protein Kinase Cδ, and p38 Mitogen-activated Protein Kinase (MAPK)
Edward Thorp et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Continued clearance of apoptotic cells critically depends on the phagocyte Ucp2 protein
Daeho Park et al.
NATURE (2011)
Atherogenic Lipids and Lipoproteins Trigger CD36-TLR2-Dependent Apoptosis in Macrophages Undergoing Endoplasmic Reticulum Stress
Tracie A. Seimon et al.
CELL METABOLISM (2010)
Non-redundant roles for LXR alpha and LXR beta in atherosclerosis susceptibility in low density lipoprotein receptor knockout mice
Eric D. Bischoff et al.
JOURNAL OF LIPID RESEARCH (2010)
Relationship of Thrombus Healing to Underlying Plaque Morphology in Sudden Coronary Death
Miranda C. A. Kramer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Cause or Consequence What Does Macrophage Apoptosis Do in Atherosclerosis?
Murray C. H. Clarke et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
Siddhartha Jaiswal et al.
CELL (2009)
PPAR-δ senses and orchestrates clearance of apoptotic cells to promote tolerance
Lata Mukundan et al.
NATURE MEDICINE (2009)
Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of Apoe-/- mice
Edward Thorp et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Genetic loss of Gas6 induces plaque stability in expeximental atherosclerosis
E. Lutgens et al.
JOURNAL OF PATHOLOGY (2008)
Optimal medical therapy with or without PCI for stable coronary disease
William E. Boden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
ApoE-/-Fas-/- C57BL/6 mice:: a novel murine model simultaneously exhibits lupus nephritis, atherosclerosis, and osteopenia
Xuebing Feng et al.
JOURNAL OF LIPID RESEARCH (2007)
Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stability
Dorien M. Schrijvers et al.
CARDIOVASCULAR RESEARCH (2007)
Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice
Vinay K. Bhatia et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte
SJ Gardai et al.
CELL (2005)
Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease
T Aprahamian et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root
D Teupser et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
LRP: Role in vascular wall integrity and protection from atherosclerosis
P Boucher et al.
SCIENCE (2003)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo
PX Shaw et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death
FD Kolodgie et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
